Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:12 PM
Ignite Modification Date:
2025-12-24 @ 10:12 PM
NCT ID:
NCT00964535
Eligibility Criteria:
Inclusion Criteria:
* Males or females aged 18-60 years with documented diagnosis of asthma
* Prebronchodilator forced expiratory volume in one second (FEV1) at least 80% of the predicted value
* The asthma should be stable on the same regular treatment for at least 4 weeks before screening.
Exclusion Criteria:
* Use of oral, parenteral or rectal corticosteroids within 4 weeks preceding the screening
* Respiratory infection within 4 weeks preceding the screening
* Any condition requiring regular concomitant treatment or likely to need concomitant treatment during the study with medicinal products which have pharmacokinetic interactions with budesonide
* Any disorder or clinically significant abnormal laboratory value or physical finding that may interfere with the interpretation of test results or cause a health risk for the subject if he/she participates in the study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
60 Years
Study:
NCT00964535
Study Brief:
Protocol Section:
NCT00964535